Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications
Pan Xie, Ming-Hui Long, Zhao-Qian Liu, Jing Wang, De-Hua Liao, Zhi-Bin Wang · 2026
Read Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications by Pan Xie, Ming-Hui Long, Zhao-Qian Liu, Jing Wang, De-Hua Liao, Zhi-Bin Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194143.txt.
Description
Pan Xie and five co-authors review a chemical tag on proteins that may shape cancer immunotherapy, in this 2026 paper. The tag, succinylation, adds a small acid group to lysine building blocks of proteins. It links how tumors burn fuel with how they face the immune system, two fields often studied apart.
The review maps the enzymes that add, remove, and read the tag, and traces its reach into core fuel cycles. It then shows how the tag steadies or breaks a key immune brake, PD-L1, and how it steers macrophages, dendritic cells, and T cells inside tumors. The same tag can help or hinder immune attack, a dual role the authors stress. They survey drugs that target the tag's enzymes and combos meant to break drug resistance, and they flag gaps in the enzyme map as the main barrier ahead.
Catalog record
| CREATOR | Pan Xie, Ming-Hui Long, Zhao-Qian Liu, Jing Wang, De-Hua Liao, Zhi-Bin Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |